ProGIGuard logo jpeg.jpg

ProGIGuard is formulated with a unique Yeast form probiotic from Lesaffre, the world largest yeast manufacturer located in France. The patented yeast strain underwent studies and was found to help:

  • Accelerates bowel transit, reduce bloating & constipation.

  • Reduce stomach sensitivity, improve resistance to stomach pain such as IBS.

  • Removes gut bad pathogens from the body. (Enterococcus, E.coli and C.albicans), restores the body's microflora balance.

  • Improves vaginal health-related conditions such as white discharge, bacterial vaginosis etc.

Website banner photos.jpg

Women have specific health and wellbeing issues, which are influenced by their genetics and hormonal fluctuations throughout their lives. These have an impact on their immunity, mood, digestive health, and so on. And what do these issues have in common? They are all related to the balance of the microflora in the endogenous body.

 

Candida is one of microbe that is commonly found in the human body. Health problems can arise when Candida overgrowth occurs — when Candida grows out of control.
 

Candida can become out of control due to a variety of factors. The following are some of the common Candida overgrowth symptoms and signs:

  • White discharge

  • Oral thrush

  • Skin changes (like acne and eczema flares)

  • Bowel issues (like constipation and diarrhoea)

  • Mood changes (like brain fog, anxiety or depression)

  • Inability to lose weight

  • Fungal infections of the skin and nails

 

Key ingredients in ProGIGuard have been clinically shown to:

 
1.jpg
2.jpg
3.jpg

Stimulates gut

motility

Binds & removes

candida and other pathogens

Increases gut

pain resistantt

Features & Benefits

ProGiguard icon.jpg

Relieves interval constipation issue

ProGiguard icon.jpg

Restores & balances microflora

ProGiguard icon.jpg

Relieves gut discomfort & pain such as IBS incidences

Reduces female white discharge

& BV recurrence incidence.

ProGiguard icon.jpg
ProGiguard icon.jpg

Relieves bloating

ProGiguard icon.jpg

Supports immune health

ProGIGuard banner.jpg

Natural ingredients that have been clinically studied

Most probiotic supplements in the market are formulated with bacterial strains. ProGIGuard contains the patented yeast strain probiotic Saccharomyces Cerevisiae CNCM I-3856, another probiotic contender that is increasing in popularity and has gained recognition from the medical and scientific community. It is a patented yeast strain produced by Lesaffre, the world largest yeast manufacturer located in France.

ProGIGuard Ingredients and Usage

 

Directions:

Treatment: Take 2 capsules two times daily before meal

Maintainence: Take 2 capsules once daily before meal

*recommend to take after food for those with highly sensitive stomach.

Keep it in a cool, dry place. Keep out of children's reach.

Not suitable for women and children.

Each ProGIGuard vegetable capsule contains:

 

Saccharomyces cerevisiae CNCM I-3856     250mg

 

Frequently asked questions

Who should take The PrimAGE ProGIGuard?


Those with candida overgrowth related signs and symptoms, such as: - Female with frequent recurrence of vaginal infection incidences such white discharge, bacteria vaginosis (BV). - Having irritable bowel syndrome related symptoms. - Interval constipation. - Frequent bloating.




How soon can I see results after taking The PrimAGE ProGIGuard?


Digestive Health 77% of consumers experienced ProGIGuard efffect within 15 days of consumption. (1) 96% of consumers satisfaction. (1) Vaginal Health starts to take effect after 7 days of consumtion, 57% reduction in candida load in vaginal vs 33% in the placebo group, after second month consumption.(2) Decreases the risks of recurrence by 54% and accelerates C.albicans clearance after 2 months.(2)
1. Satisfaction reported during a survey performed on 1161 volunteers. Taban J. Soigner le patient colopathe, La revue Pharma. 2015 October, 125: 44 2. July 2016: Medical Journal of Obstetrics and Gynecology Saccharomyces cerevisiae CNCM I-3856 as a natural breakthrough for vaginal health: A clinical study. Amelie Cayzeela-Decherf, Fanny Pelerin and Peter Justen.





Topics you may like: